Treatment based on symptoms instead of blood values The recommended treatment in the Netherlands consists of a hydroxocobalamin injection of 1mg every two months, after an initial loading dose of 10 injections in 5 to 10 weeks
We monitor the patient during follow-up visits to evaluate progress, track energy levels, and observe how their body responds to treatment over time
Each step often requires flow sorting, drug selection and often clone screening, resulting in weeks to months per allele of interest
EC 1.2.1.47) oxidizes TMABA to -butyrobetaine (-BB) as shown for Pseudomonas sp
Other Risk Factors Autonomic disturbances may surface between episodes, including fainting or reflex sympathetic dystrophy, a chronic pain condition
BTX DMAE is the ideal product to combat the first signs of ageing